DOCSLIB.ORG

Meeting Program

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Meeting Program BOARD OF DIRECTORS Warren K. Bickel, PhD, President William L. Dewey, PhD Chris-Ellyn Johanson, PhD, Past-President Nicholas E. Goeders, PhD Kathryn A. Cunningham, PhD, President-Elect Martin Y. Iguchi, PhD Dorothy K. Hatsukami, PhD, Treasurer Sari Izenwasser, PhD Leslie Amass, PhD Herbert D. Kleber, MD James C. Anthony, PhD Thomas R. Kosten, MD Nancy A. Ator, PhD Horace H. Loh, PhD Anna Rose Childress, PhD S. Stevens Negus, PhD Thomas J. Crowley, MD Sharon Walsh, PhD Samuel A. Deadwyler, PhD EXECUTIVE OFFICER Martin W. Adler, PhD SCIENTIFIC PROGRAM COMMITTEE Sharon Walsh, PhD, Chair Scott E. Lukas, PhD, Past-Chair Martin W. Adler, PhD, ex officio Ellen B. Geller, MA, ex officio Patrick Beardsley, PhD Richard Glennon, PhD Leonard Handelsman, MD Arthur Horton, EdD Sari Izenwasser, PhD Gary B. Kaplan, MD Anthony Liguori, PhD Edythe London, PhD Athina Markou, PhD S. Michael Owens, PhD Linda J. Porrino, PhD Andrew J. Saxon, MD Sandra Welch, PhD Saturday, June 18, 2005 PRE-MEETING SATELLITES The International Study Group Investigating Crown Hall Drugs as Reinforcers (ISGIDAR) Chaired by Michael A. Nader 5 th Annual Meeting Center for Substance Abuse Treatment (CSAT) Great Hall East Science to Services and Services to Science: The Identification and Adoption of Effective Practices for Substance Abuse Treatment Chaired by Karl D. White The 10th Annual NIDA International Forum on England Building International Research on Drug Abuse: Progress through Collaboration Chaired by Steven Gust Translating Basic Research from Neural, Behavioral, Ireland and Social Sciences to Prevention: Challenges and Opportunities Food, Drugs, Obesity and Addiction: Common Scotland C Neurobiologic Processes? Chaired by Nora D. Volkow and Joseph Frascella CPDD REGISTRATION Great Hall Assembly Saturday, June 18 1:30 PM - 5:30 PM Sunday, June 19 8:00 AM - 12:00 PM 2:00 PM - 5:30 PM Monday, June 20 8:00 AM - 1:00 PM 2:00 PM - 5:00 PM Tuesday, June 21 8:00 AM - 1:00 PM Wednesday, June 22 8:00 AM - 12:30 PM 2:00 PM - 5:00 PM Thursday, June 23 7:30 AM - 1:00 PM OPENING RECEPTION 7:00 – 9:00 PM (Cash Bar) Pool Area xii Sunday, June 19, 2005 Sunday, June 19, 2005 CSAT TRAVEL AWARDEES BREAKFAST Grosvenor Resort (By Invitation Only) 7:00 - 8:30 AM Plenary Session Great Hall 8:30 - 11:00 AM 8:30 Welcome Warren K. Bickel, President, CPDD 8:45 Report from the National Institute on Drug Abuse Nora D. Volkow, Director, NIDA 9:15 Presentation of the Meritorious Service Award to Ian P. Stolerman Introduction by Chris-Ellyn Johanson, 9:20 Presentation of the Media Award to Brian Vastag Introduction by Marc J. Kaufman, 9:25 Presentation of the Joseph Cochin Young Investigator Award to Thomas E. Eissenberg Introduction by Robert L. Balster, 9:30 Presentation of the Joseph Cochin Young Investigator Award to James K. Rowlett Introduction by William L. Woolverton, 9:35 Presentation of the Mentorship Award to Linda A. Dykstra Introduction by Alison Oliveto-Beaudoin, 9:40 Presentation of the Nathan B. Eddy Award to Conan Kornetsky Introduction by George F. Koob, 9:45 Nathan B. Eddy Award Lecture A walk through the history of drug abuse: Research, trends and fads Conan Kornetsky, Boston University School of Medicine, Boston, MA President’s Lecture Great Hall 1:00 - 2:00 PM COGNITIVE SEQUELAE OF DRUG ABUSE: STUDIES IN HUMANS AND EXPERIMENTAL ANIMALS Trevor Robbins University of Cambridge, UK 1 Sunday, June 19, 2005 Symposium I Scotland 2:00 - 4:00 PM DRUGS OF ABUSE AND REGULATORS OF G-PROTEIN SIGNALING Chairs: John Traynor and Richard Neubig 2:00 Just what are RGS proteins? David Siderovski, The University of North Carolina at Chapel Hill, Chapel Hill, NC 2:25 RGS protein modulation of abuse liability properties of opioids and stimulants John Traynor, University of Michigan Medical School, Ann Arbor, MI 2:50 Regulation of RGS proteins by drugs of abuse Stephen Gold, UT Southwestern Medical Center at Dallas, Dallas, TX 3:15 Inhibitors of RGS protein activity Richard Neubig, University of Michigan Medical School, Ann Arbor, MI 3:40 RGS proteins as targets for drug abuse treatment medications Discussant: Richard B. Rothman, NIH/NIDA Intramural Research Program, Baltimore, MD Symposium II England 2:00 - 4:00 PM NICOTINE DEPENDENCE AND PSYCHIATRIC DISORDERS: TREATMENT IMPLICATIONS Chairs: Ivan D. Montoya and Himanshu P. Upadhyaya 2:00 Biological determinants of nicotine dependence in severe mental disorders: Cognitive deficits and genetic polymorphisms as targets for therapeutics development Tony P. George, Yale University, Connecticut Mental Health Center, New Haven, CT 2:25 Treatment of nicotine dependence in individuals with schizophrenia Douglas M. Ziedonis, Robert Wood Johnson Medical School, Piscataway, NJ 2:50 Treatment of comorbid ADHD and nicotine dependence Himanshu P. Upadhyaya, Medical University of South Carolina, Charleston, SC 3:15 Current research and future directions for treating nicotine dependence among illicit drug users Kimber P. Richter, University of Kansas Medical Center, Kansas City, KS 3:40 Discussant Lirio S. Convey, Columbia University and New York State Psychiatric Institute, New York, NY 2 Sunday, June 19, 2005 Oral Communications I Crown Hall 2:00 - 4:00 PM MDMA: IS IT REALLY ECSTASY? Chairs: Richard A. Glennon and Chris-Ellyn Johanson 2:00 Pizotyline fully antagonizes the discriminative stimulus effects of MDMA R.A. Glennon and R. Young, Virginia Commonwealth University, Richmond, VA 2:15 Consequences of exposure to neurotoxic regimens of methamphetamine and MDMA (ecstasy) on cognitive paradigms in mice C. Achat-Mendes, S.F. Ali and Y. Itzhak, University of Miami School of Medicine, FL and NCTR, FDA, Jefferson, AR 2:30 3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) elicits context-dependent locomotor and electrophysiological sensitization in freely moving rats K.T. Ball, D. Budreau and G.V. Rebec, Indiana University, Bloomington, IN 2:45 Tolerance to behavioral and neuroendocrine effects of ecstasy (MDMA) in rats M.H. Baumann, F.H. Franken, J.J. Rutter, R.D. Clark and R.B. Rothman, NIH/NIDA Intramural Research Program, Baltimore, MD 3:00 Effects of ecstasy (MDMA) on plasma serotonin in rats: In vivo and in vitro evaluation D. Zolkowska, M.H. Baumann, R.D. Clark and R.B. Rothman, NIH/NIDA Intramural Research Program, Baltimore, MD 3:15 MDMA-induced hyperthermia in rhesus monkeys M.A. Taffe, S.N. Katner, C.C. Lay, S.N. Von Huben, R.D. Crean, S.A. Davis and A.J. Kirsten, The Scripps Research Institute, La Jolla, CA 3:30 The effects of MDMA on sleep architecture and subsequent mood in humans C.E. Johanson, T. Roehrs and M. Tancer, Wayne State University, Detroit, MI and Henry Ford Hospital, Detroit, MI 3:45 Striatal dopamine release during a motorbike riding computer game in novelty seekers and recreational ecstasy users in SPECT A.M. Weinstein, M. Greemland, H. Lerman, I. Herman, S. Schreiber, R. Bar-Hamburger and E. Even-Sapir, Sourasky Medical Center, Tel Aviv, Jaffa Treatment Center for Drug Victims, Israel and Israeli-Anti Drug Authority, Jerusalem, Israel Oral Communications II Ireland 2:00 - 3:00 PM MISUSED PRESCRIPTION DRUGS: CRUELLA DE PILL Chairs: James A. Inciardi and Curtis Wright 2:00 Trends in the diversion of prescription opioids in the United States J.A. Inciardi, A. Hernandez, J.L. Goode and Y. Lugo, University of Delaware, Center for Drug and Alcohol Studies, Coral Gables, FL 2:15 Characteristics of nonmedical users of hydromorphone: Results from the National Survey on Drug Use and Health J.D. Haddox, M.Y. Smith and C. Wright IV, Purdue Pharma L.P., Stamford, CT 3 Sunday, June 19, 2005 2:30 Characterizing controlled-release oxycodone abuse in a Canadian treatment facility B.A. Sproule, B. Brands and L. Catz-Biro, University of Toronto, Toronto, Canada 2:45 Antecedents of prescription opioid abuse in the CARDIA study M.J. Pletcher, S. Kertesz, S. Sidney, C.I. Kiefe and S.B. Hulley, University of California, San Francisco, CA, University of Alabama at Birmingham, AL and Kaiser Permanente Division of Research, Oakland, CA Oral Communications III Ireland 3:30 - 4:30 PM POLICY IN THE CLINIC AND COURTROOM Chairs: Cynthia L. Arfken and Jennifer P. Wisdom 3:30 Who provides specialized programs for criminal justice populations? C.L. Arfken, S.P. Kubiak, A. Koch and J. Roddy, Wayne State University, Detroit, MI 3:45 Substance-use patterns in drug court: No problem? D.S. DeMatteo, D.S. Festinger, P.A. Lee and D.B. Marlowe, Treatment Research Institute, Philadelphia, PA 4:00 Towards an agreement about evaluation instruments in health care units on drug abuse in the autonomous region of Valencia (Spain) C. Morales, A. Vidal, M. Castellano, P. De Vicente, J.C. Perez de los Cobos, R. Aleixandre, S. Tortajada and J.C. Valderrama, Instituto de Historia de la Ciencia y Documentación Lopez Piñero (UV-CSIC), FEPAD, Generalitat Valenciana and Hospital de la Santa Creu i Sant Pau, Valencia, Spain 4:15 Process improvement to increase access and retention: Real-world application in a women- focused substance abuse treatment agency J.P. Wisdom, E. Gifford, and N. Roget, Oregon Health and Science University, Portland, OR and Center for Health Care Evaluation, VA Palo Alto Health Care System, Palo Alto, and Stanford University School of Medicine, Stanford, CA Symposium III England 4:45 - 5:45 PM TREATMENT OF THE PREGNANT ADDICT: FROM THE LABORATORY TO THE CLINIC Chairs: Mahmoud S. Ahmed and Amrat Patel 4:45 Effects of a nicotine vaccine on nicotine transfer to the fetus in rats: A model of pharmacokinetic approaches at reducing fetal exposure to addictive drugs Paul Pentel, Hennepin County Medical Center, Minneapolis, MN 5:05 Noninvasive assessment of fetal brain activity Curtis L.
Load more

Recommended publications
  • Addictions and the Brain
    9/18/2012 Addictions and the Brain TAAP Conference September 14, 2012 Acknowledgements • La Hacienda Treatment Center • American Society of Addiction Medicine • National Institute of Drug Abuse © 2012 La Hacienda Treatment Center. All rights reserved. 1 9/18/2012 Definition • A primary, progressive biochemical, psychosocial, genetically transmitted chronic disease of relapse who’s hallmarks are denial, loss of control and unmanageability. DSM IV Criteria for dependency: At least 3 of the 7 below 1. Withdrawal 2. Tolerance 3. The substance is taken in larger amounts or over a longer period than was intended. 4. There is a persistent desire or unsuccessful efforts to cut down or control substance use. 5. A great deal of time is spent in activities necessary to obtain the substance, use the substance, or recover from its effects. 6. Important social, occupational, or recreational activities are given up or reduced because of the substance use. 7. The substance use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance. © 2012 La Hacienda Treatment Center. All rights reserved. 2 9/18/2012 Dispute between behavior and disease Present understanding of the Hypothalamus location of the disease hypothesis. © 2012 La Hacienda Treatment Center. All rights reserved. 3 9/18/2012 © 2012 La Hacienda Treatment Center. All rights reserved. 4 9/18/2012 © 2012 La Hacienda Treatment Center. All rights reserved. 5 9/18/2012 Dispute regarding behavior versus disease © 2012 La Hacienda Treatment Center. All rights reserved. 6 9/18/2012 © 2012 La Hacienda Treatment Center.
    [Show full text]
  • Upregulation of Peroxisome Proliferator-Activated Receptor-Α And
    Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer Chih-Yang Wang, Ying-Jui Chao, Yi-Ling Chen, Tzu-Wen Wang, Nam Nhut Phan, Hui-Ping Hsu, Yan-Shen Shan, Ming-Derg Lai 1 Supplementary Table 1. Demographics and clinical outcomes of five patients with ampullary cancer Time of Tumor Time to Age Differentia survival/ Sex Staging size Morphology Recurrence recurrence Condition (years) tion expired (cm) (months) (months) T2N0, 51 F 211 Polypoid Unknown No -- Survived 193 stage Ib T2N0, 2.41.5 58 F Mixed Good Yes 14 Expired 17 stage Ib 0.6 T3N0, 4.53.5 68 M Polypoid Good No -- Survived 162 stage IIA 1.2 T3N0, 66 M 110.8 Ulcerative Good Yes 64 Expired 227 stage IIA T3N0, 60 M 21.81 Mixed Moderate Yes 5.6 Expired 16.7 stage IIA 2 Supplementary Table 2. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of an ampullary cancer microarray using the Database for Annotation, Visualization and Integrated Discovery (DAVID). This table contains only pathways with p values that ranged 0.0001~0.05. KEGG Pathway p value Genes Pentose and 1.50E-04 UGT1A6, CRYL1, UGT1A8, AKR1B1, UGT2B11, UGT2A3, glucuronate UGT2B10, UGT2B7, XYLB interconversions Drug metabolism 1.63E-04 CYP3A4, XDH, UGT1A6, CYP3A5, CES2, CYP3A7, UGT1A8, NAT2, UGT2B11, DPYD, UGT2A3, UGT2B10, UGT2B7 Maturity-onset 2.43E-04 HNF1A, HNF4A, SLC2A2, PKLR, NEUROD1, HNF4G, diabetes of the PDX1, NR5A2, NKX2-2 young Starch and sucrose 6.03E-04 GBA3, UGT1A6, G6PC, UGT1A8, ENPP3, MGAM, SI, metabolism
    [Show full text]
  • Design and Synthesis of Cyclic Analogs of the Kappa Opioid Receptor Antagonist Arodyn
    Design and synthesis of cyclic analogs of the kappa opioid receptor antagonist arodyn By © 2018 Solomon Aguta Gisemba Submitted to the graduate degree program in Medicinal Chemistry and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. Chair: Dr. Blake Peterson Co-Chair: Dr. Jane Aldrich Dr. Michael Rafferty Dr. Teruna Siahaan Dr. Thomas Tolbert Date Defended: 18 April 2018 The dissertation committee for Solomon Aguta Gisemba certifies that this is the approved version of the following dissertation: Design and synthesis of cyclic analogs of the kappa opioid receptor antagonist arodyn Chair: Dr. Blake Peterson Co-Chair: Dr. Jane Aldrich Date Approved: 10 June 2018 ii Abstract Opioid receptors are important therapeutic targets for mood disorders and pain. Kappa opioid receptor (KOR) antagonists have recently shown potential for treating drug addiction and 1,2,3 4 8 depression. Arodyn (Ac[Phe ,Arg ,D-Ala ]Dyn A(1-11)-NH2), an acetylated dynorphin A (Dyn A) analog, has demonstrated potent and selective KOR antagonism, but can be rapidly metabolized by proteases. Cyclization of arodyn could enhance metabolic stability and potentially stabilize the bioactive conformation to give potent and selective analogs. Accordingly, novel cyclization strategies utilizing ring closing metathesis (RCM) were pursued. However, side reactions involving olefin isomerization of O-allyl groups limited the scope of the RCM reactions, and their use to explore structure-activity relationships of aromatic residues. Here we developed synthetic methodology in a model dipeptide study to facilitate RCM involving Tyr(All) residues. Optimized conditions that included microwave heating and the use of isomerization suppressants were applied to the synthesis of cyclic arodyn analogs.
    [Show full text]
  • Poisons and Narcotic Drugs (Amendment) Ordinance 1988
    AUSTRALIAN CAPITAL TERRITORY Poisons and Narcotic Drugs (Amendment) Ordinance 1988 No. 96 of 1988 I, THE GOVERNOR-GENERAL of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Ordinance under the Seat of Government (Administration) Act 1910. Dated 15 December 1988 N. M. STEPHEN Governor-General By His Excellency’s Command, CLYDE HOLDING Minister of State for the Arts and Territories An Ordinance to amend the Poisons and Narcotic Drugs Ordinance 1978 Short title 1. This Ordinance may be cited as the Poisons and Narcotic Drugs (Amendment) Ordinance 1988.1 Commencement 2. This Ordinance commences on such date as is fixed by the Minister by notice in the Gazette. Principal Ordinance 3. In this Ordinance, “Principal Ordinance” means the Poisons and Narcotic Drugs Ordinance 1978.2 (Ord. 79/88)—Cat. No. Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au 2 Poisons and Narcotic Drugs (Amendment) No. 96, 1988 Substances to which Division applies 4. Section 27B of the Principal Ordinance is amended by adding at the end the following paragraphs: “; (f) follicle stimulating hormone; (g) luteinising hormone; (h) thalidomide.”. Grant of authorisation 5. Section 27E of the Principal Ordinance is amended— (a) by omitting from paragraph (1) (a) “or cyclofenil” and substituting “, cyclofenil, follicle stimulating hormone or luteinising hormone”; (b) by omitting from paragraph (1) (b) “and”; and (c) by adding at the end of subsection (1) the following word and paragraph: “; and (d) in the case of an application that relates to thalidomide— the applicant is a specialist physician with no less than 5 years’ experience in the treatment of erythema nodosum leprosum.”.
    [Show full text]
  • Characterization of Mice with Altered Dopamine Transporter and Vesicular Monoamine Transporter 2 Levels
    Characterization of Mice with Altered Dopamine Transporter and Vesicular Monoamine Transporter 2 Levels by Shababa Tanzeel Masoud A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Pharmacology and Toxicology University of Toronto © Copyright by Shababa Tanzeel Masoud 2017 Characterization of Mice with Altered Dopamine Transporter and Vesicular Monoamine Transporter 2 Levels Shababa Tanzeel Masoud Doctor of Philosophy Department of Pharmacology and Toxicology University of Toronto 2017 Abstract Dopamine is a key neurotransmitter that regulates motor coordination and dysfunction of the dopamine system gives rise to Parkinson’s disease. Nigrostriatal dopamine neurons are vulnerable to various genetic and environmental insults, suggesting that these cells are inherently at-risk. A cell-specific risk factor for these neurons is the neurotransmitter, dopamine itself. If intracellular dopamine is not appropriately sequestered into vesicles, it can accumulate in the cytosol. Cytosolic dopamine is highly reactive and can trigger oxidative stress, leading to cellular toxicity. Cytosolic dopamine levels are modulated by the plasma membrane dopamine transporter (DAT) that takes up dopamine from the extracellular space, and the vesicular monoamine transporter 2 (VMAT2) that stores dopamine into vesicles. In this thesis, we altered DAT and VMAT2 levels to investigate the detrimental consequences of potentially amplifying cytosolic dopamine in transgenic mice. Project 1 focused on selective over-expression of DAT in dopaminergic cells of transgenic mice (DAT-tg). DAT-tg mice displayed phenotypes of dopaminergic damage: increased dopamine-specific oxidative stress, L-DOPA-reversible fine motor deficits and enhanced sensitivity to toxicant insult, suggesting that increasing DAT- mediated dopamine uptake is detrimental for dopamine cells.
    [Show full text]
  • Pdf; Chi 2015 DPP Air in Cars.Pdf; Dodson 2014 DPP Dust CA.Pdf; Kasper-Sonnenberg 2014 Phth Metabolites.Pdf; EU Cosmetics Regs 2009.Pdf
    Bouge, Cathy (ECY) From: Nancy Uding <[email protected]> Sent: Friday, January 13, 2017 10:24 AM To: Steward, Kara (ECY) Cc: Erika Schreder Subject: Comments re. 2016 CSPA Rule Update - DPP Attachments: DPP 131-18-0 exposure.pdf; Chi 2015 DPP air in cars.pdf; Dodson 2014 DPP dust CA.pdf; Kasper-Sonnenberg 2014 phth metabolites.pdf; EU Cosmetics Regs 2009.pdf Please accept these comments from Toxic-Free Future concerning the exposure potential of DPP for consideration during the 2016 CSPA Rule update. Regards, Nancy Uding -- Nancy Uding Grants & Research Specialist Toxic-Free Future 206-632-1545 ext.123 http://toxicfreefuture.org 1 JES-00888; No of Pages 9 JOURNAL OF ENVIRONMENTAL SCIENCES XX (2016) XXX– XXX Available online at www.sciencedirect.com ScienceDirect www.elsevier.com/locate/jes Determination of 15 phthalate esters in air by gas-phase and particle-phase simultaneous sampling Chenchen Chi1, Meng Xia1, Chen Zhou1, Xueqing Wang1,2, Mili Weng1,3, Xueyou Shen1,4,⁎ 1. College of Environmental & Resource Sciences, Zhejiang University, Hangzhou 310058, China 2. Zhejiang National Radiation Environmental Technology Co., Ltd., Hangzhou 310011, China 3. School of Environmental and Resource Sciences, Zhejiang Agriculture and Forestry University, Hangzhou 310058, China 4. Zhejiang Provincial Key Laboratory of Organic Pollution Process and Control, Hangzhou 310058, China ARTICLE INFO ABSTRACT Article history: Based on previous research, the sampling and analysis methods for phthalate esters (PAEs) Received 24 December 2015 were improved by increasing the sampling flow of indoor air from 1 to 4 L/min, shortening the Revised 14 January 2016 sampling duration from 8 to 2 hr.
    [Show full text]
  • Opioid Receptorsreceptors
    OPIOIDOPIOID RECEPTORSRECEPTORS defined or “classical” types of opioid receptor µ,dk and . Alistair Corbett, Sandy McKnight and Graeme Genes encoding for these receptors have been cloned.5, Henderson 6,7,8 More recently, cDNA encoding an “orphan” receptor Dr Alistair Corbett is Lecturer in the School of was identified which has a high degree of homology to Biological and Biomedical Sciences, Glasgow the “classical” opioid receptors; on structural grounds Caledonian University, Cowcaddens Road, this receptor is an opioid receptor and has been named Glasgow G4 0BA, UK. ORL (opioid receptor-like).9 As would be predicted from 1 Dr Sandy McKnight is Associate Director, Parke- their known abilities to couple through pertussis toxin- Davis Neuroscience Research Centre, sensitive G-proteins, all of the cloned opioid receptors Cambridge University Forvie Site, Robinson possess the same general structure of an extracellular Way, Cambridge CB2 2QB, UK. N-terminal region, seven transmembrane domains and Professor Graeme Henderson is Professor of intracellular C-terminal tail structure. There is Pharmacology and Head of Department, pharmacological evidence for subtypes of each Department of Pharmacology, School of Medical receptor and other types of novel, less well- Sciences, University of Bristol, University Walk, characterised opioid receptors,eliz , , , , have also been Bristol BS8 1TD, UK. postulated. Thes -receptor, however, is no longer regarded as an opioid receptor. Introduction Receptor Subtypes Preparations of the opium poppy papaver somniferum m-Receptor subtypes have been used for many hundreds of years to relieve The MOR-1 gene, encoding for one form of them - pain. In 1803, Sertürner isolated a crystalline sample of receptor, shows approximately 50-70% homology to the main constituent alkaloid, morphine, which was later shown to be almost entirely responsible for the the genes encoding for thedk -(DOR-1), -(KOR-1) and orphan (ORL ) receptors.
    [Show full text]
  • Annual Review of EU Trademark
    Annual Review of EU Trademark Law 2015 in Review Guy Heath—Nabarro LLP London, United Kingdom with Georg Jahn—Noerr LLP Munich, Germany Anne Marie Verschuur—NautaDutilh Amsterdam, The Netherlands Jordi Güell—Curell Suñol Barcelona, Spain Pier Luigi Roncaglia—Studio Legale SIB Florence, Italy Meriem Loudiyi—INLEX Paris, France Ivo Rungg—Binder Grösswang Vienna, Austria Nina Ringen—Rønne & Lundgren Copenhagen, Denmark Johan Norderyd—Lindahl Malmö, Sweden Tanguy de Haan—NautaDutilh Brussels, Belgium March–April, 2016 Vol. 106 No. 2 INTERNATIONAL TRADEMARK ASSOCIATION Powerful Network Powerful Brands 655 Third Avenue, New York, NY 10017-5646 Telephone: +1 (212) 768-9887 email: [email protected] Facsimile: +1 (212) 768-7796 OFFICERS OF THE ASSOCIATION RONALD VAN TUIJL .................................................................................................................. President JOSEPH FERRETTI ...........................................................................................................President Elect TISH L. BERARD .............................................................................................................. Vice President DAVID LOSSIGNOL ........................................................................................................... Vice President AYALA DEUTSCH ..................................................................................................................... Treasurer TIKI DARE ..............................................................................................................................
    [Show full text]
  • The State of Food and Agriculture, 1954
    iilliiill 111111111111 1111 .11 ii111111 11 iiiiiill 11111111 11111111111 1111 11 Review and Outioo 11 11 11 11 11 1111 11111 11 1111111 111111111 uu ' 1111111111i 1111111111111 111 III pill!! 1111 111111111 11 HO 11 11 11111111 dK¿,1tur u,11 11 11 11 1111 11 1111111 YL AN[ fiULTi -STICS-1953 _RT I- PRODUCTION Part I provides basic statistics on world agricultural production.It gives authoritative infor- mation on landuse, agricultural population, crops, livestock numbers and products, food supplies and their utilization, and on commercial fertilizers, pesticides, and agricultural machinery.It also includes the more important series of agricultural commodity prices in many countries, as well asindex numbers of prices received and paidby farmers, and of agricultural production. PART II- TRADE The second partisa basic reference work on world trade in agricultural products and gives statistics of the imports and exports of the major agricultural commodities.It includes regional and world totals, computed from official and unofficial information.For some major commodities, data are given by trade season aswell as by calendar year. This two-volume yearbookisa valuable reference work for importers, exporters, and com- mercial houses, as well as official bodies concerned with food and agriculture.Itis available from any bookseller, or from any of the FAO sales agents listed on the back cover of this publication. Price :Each part $3.50 or 17s.6d FAO STATISTICAP, PUBLIC L'IONS Monthly Bulletin of Agricultural Economics and Statistics Single copy $0.50, 2s.6d. Annual subscription $5.00, 25s. This bulletin gives statistics of production, trade and prices based on information available on the 25th of the month preceding that of issue.Each number contains one or two articles on mat- ters of current interest in the field of agricultural economics, and a section of commodity notes.
    [Show full text]
  • © 2014 Alejandro Jose Gomez-Del-Moral ALL RIGHTS
    © 2014 Alejandro Jose Gomez-del-Moral ALL RIGHTS RESERVED BUYING INTO CHANGE: CONSUMER CULTURE AND THE DEPARTMENT STORE IN THE TRANSFORMATION(S) OF SPAIN, 1939-1982 By ALEJANDRO JOSE GOMEZ-DEL-MORAL A dissertation submitted to the Graduate School-New Brunswick Rutgers, The State University of New Jersey In partial fulfillment of the requirements For the degree of Doctor of Philosophy Graduate Program in History Written under the direction of Temma Kaplan And approved by ________________________________ ________________________________ ________________________________ ________________________________ New Brunswick, New Jersey October 2014 ABSTRACT OF THE DISSERTATION Buying Into Change: Consumer Culture and the Department Store in the Transformation(s) of Spain, 1939-1982 by ALEJANDRO JOSE GOMEZ-DEL-MORAL Dissertation Director: Temma Kaplan This dissertation examines how the development of a mass consumer society during the dictatorship of Generalissimo Francisco Franco (1939-1975) inserted Spain into transnational consumer networks and drove its democratization. As they spread, Spain’s first modern department stores, supermarkets, consumer magazines, and advertising helped create a public sphere when the Franco regime had curtailed opportunities for public life. In these stores, Spanish consumers encountered foreign products and lifestyles that signaled cosmopolitanism and internationalism, undermining the dictatorship’s foundational discourse of Spanish exceptionalism. With these products came subversive ideas on issues like gender equality,
    [Show full text]
  • The State of Food and Agriculture, 1952
    THE oTATE OF FOOD A ji cucruiri, 0 REVIEW AND OUTLOOK 1952 FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS ROME, ITALY OCTOBER 1952 FAO STATISTICAL YEARBOOKS Yr:P=3,7=3 OF FOOD AND AGRICULTURAL STATISTICS, 1947, 1948, 1949, 1950, 1951 I- PRODUCTION II- TRADE These two-volume yearbooks continue the statistical series begun by the International Institute of Agriculture which was absorbed into FAO in 1946.The volumes on Production contain statistical data on crops and livestock numbers and the Trade volumes (publication started in 1948) present statisticalinformation on international trade in the major agricultural products of the world.Production 1947 covers the years 1940/41 to 1945/46, as well as prewar averages for crops and livestock products ; Production 1948 covers 1946/47 and adds figures on total population by countries and on persons engaged in agricultural occupations ; Trade 1950 contains statistics and notes covering the years 1946, 1947 1948 and 1949, compared with an average for earlier years.The volume on Trade 1951 contains new figures for 1950 and the latest revised data for the years 1947, 1948 and 1949, compared with the prewar (1934-38) average.The 1952 volumes are now in preparation. Bilingual English/French, with notes and glossary in Spanish.Per volume $3.5017/6 YEARBOOKS OF FISHERIES STATISTICS, 1947, 1948-49 The statistical coverage begins with 1938 and ends with 1949.For identification of species a nomenclature section lists scientific and common names by country.1948-49, the second yearbook, continues and expands the data published in 1947, which were supplemented throughout 1948 and 1949 by statistics published in FAO Fisheries Bulletin.In addition to the above, the 1950-51 volume is now in preparation.
    [Show full text]
  • Year in Review 2018/2019
    Contents Shaping the Museum of the Future 2 Philanthropy on View 4 The Year at a Glance 8 Compelling Mix of Original and Touring Exhibitions 12 ROM Objects on Loan Locally and Globally 26 Leading-Edge Research 36 ROM Scholarship in Print 46 Community Connections 50 Access to First Peoples Art and Culture 58 Programming That Inspires 60 Learning at the ROM 66 Members and Volunteers 70 Digital Readiness 72 Philanthropy 74 ROM Leadership 80 Our Supporters 86 2 royal ontario museum year in review 2018–2019 3 One of the initiatives we were most proud of in 2018 was the opening of the Daphne Cockwell Gallery dedicated to First Peoples art & culture as free to the public every day the Museum is open. Initiatives such as this represent just one step on our journey. ROM programs and exhibitions continue to be bold, ambitious, and diverse, fostering discourse at home and around the world. Being Japanese Canadian: reflections on a broken world, Gods in My Home: Chinese New Year with Ancestor Portraits and Deity Prints and The Evidence Room helped ROM visitors connect past to present and understand forces and influences that have shaped our world, while #MeToo & the Arts brought forward a critical conversation about the arts, institutions, and cultural movements. Immersive and interactive exhibitions such as aptured in these pages is a pivotal Zuul: Life of an Armoured Dinosaur and Spiders: year for the Royal Ontario Museum. Fear & Fascination showcased groundbreaking Shaping Not only did the Museum’s robust ROM research and world-class storytelling. The Cattendance of 1.34 million visitors contribute to success achieved with these exhibitions set the our ranking as the #1 most-visited museum in stage for upcoming ROM-originals Bloodsuckers: the Canada and #7 in North America according to The Legends to Leeches, The Cloth That Changed the Art Newspaper, but a new report by Deloitte shows World: India’s Painted and Printed Cottons, and the the ROM, through its various activities, contributed busy slate of art, culture, and nature ahead.
    [Show full text]